In view of the uncertainty about safe limits of steroid dosage and of the particular interest in the 5 mg. per day dose level (de Andrade, McCormick, and Hill, 1964) , we studied adrenal cortical responsiveness in a series of patients with rheumatoid arthritis, who had been on this dose of prednisone for varying periods, by the Synacthen test (Wood, Frankland, James, and Landon, 1965) .
In view of the uncertainty about safe limits of steroid dosage and of the particular interest in the 5 mg. per day dose level (de Andrade, McCormick, and Hill, 1964) , we studied adrenal cortical responsiveness in a series of patients with rheumatoid arthritis, who had been on this dose of prednisone for varying periods, by the Synacthen test (Wood, Frankland, James, and Landon, 1965) .
Material
Patients.-39 patients were studied, all but one of whom had taken prednisone 5 mg./day for periods of from 8 weeks to 8 years. One patient (Case 31) had her dose increased from 5 to 7 mg./day 8 months before the test. With the exception of two who had polymyalgia rheumatica, all had rheumatoid arthritis. Of these 39 patients, nineteen were selected at random and studied again after a year to discover the effects of continued or altered prednisone dosage upon adrenal function. Control.-Twenty normal hospitalized controls of comparable age range were studied under the same test conditions as the patients.
Methods
Plasma "cortisol" was estimated by a modification of the technique of Mattingly (1962) for free 11-hydroxycorticoids. In this technique both cortisol and corticosterone are measured. The amounts of circulating corticosterone are small and since the present study is essentially comparative, the result is referred to as plasma "cortisol". Prednisone does not interfere with the estimated result by more than I per cent.
Synacthen Test.-All tests were carried out on nonfasting subjects starting between 9 and 10 a.m. None of the patients had taken any steroid for at least 12 hours before the test. Between 9 and 10 a.m. samples of venous blood were collected for the estimation of resting levels of plasma cortisol. 250 pg. Synacthen in 0 5 ml. sterile water were then injected intramuscularly. A sample of blood was collected at 30 and 60 minutes after the injection of Synacthen. The 60-minute samples were estimated in all cases. Although these latter values are not given in the Tables of results they were used to confirm the 30-minute values in order to exclude the possibility of a delay in absorption as being the cause of an abnormal response.
Results
In the twenty normal control subjects, the resting level of plasma "cortisol" at 9 a.m. varied between 7 0 and 22 * 7 ,ug./100 ml. (mean 14 9 ug.); 30 minutes after the injection of Synacthen values varied between 25 5 and 36 5 ,pg./100 ml. (mean 31 ,pg.).
Our criteria for a normal Synacthen test were the finding of both:
(1) A baseline plasma "cortisol" value of 7 pg./100 ml. or more.
(2) An increment at 30 minutes of 10,ug./100 ml. or more on the baseline value.
These ciiteria are in accordance with those of other workers (Wood and others, 1965; Greig, Browning, Boyle, and Maxwell, 1966) . Table I (overleaf) shows the results in 39 patients, whose total dose of steroid varied from 0 * 3 to 14 -2 g. prednisone, and whose period of treatment varied from 8 weeks to 8 years. They are arranged in order of total dosage which corresponds closely to the number of weeks of treatment.
No patient was found to have evidence of lack of adrenal responsiveness during the first year of treatment, but Case 21 showed an abnormal response at one year. This patient had been previously treated with steroids at another hospital, but had been on 5 mg./day for 52 weeks at this hospital. The other three patients (Cases 31, 37, 39) with a lack of adrenal response had all received large doses of steroid. Three patients (Cases 6, 16, 22) showed low baseline values but a normal increment after the Synacthen, whereas six others (Cases 1, 8, 20, 25, 26, 34) with normal baseline values showed a subnormal increment after Synacthen after variable doses of steroids. The four patients with clear evidence of lack of adrenal response (21, 31, 37, 39) are scattered in a random fashion in the Table, suggesting that individual variation in sensitivity to the 5 mg. dose is of more importance than total dose or total time. The plasma "cortisol" at 60 minutes in these four patients was still poor, suggesting that poor absorption of Synacthen was not the basis of their poor response. Discussion It has been suggested that there is a relationship between the incidence of adrenal cortical suppression and the dose and duration of treatment of steroid therapy (Savage, 1966; de Andrade and others, 1964) , but this relationship is not universally confirmed (Livanou, Ferriman, and James, 1965 no evidence that 5 mg. exogenous prednisone suppressed endogenous cortisol production during the period they studied. J0rgensen (1965) found no abnormality in the ACTH response until a total dose of 5 * 8 mg. prednisone had been given. Hamaty (1966) suggested that 18-2 g. prednisone could be tolerated as 5 mg./day for 10 years. In contrast Goth, Gorgenyi, F6venyi, and Szaint6 (1964) found abnormalities to the ACTH test developing between a total dose 1 and 2 g. of prednisone. These earlier series consist of patients on a variety of doses for a variety of times. It is therefore necessary, in using their results, to predict the progress of adrenal suppression in other patients, to assume that the figure given by multiplying the total dose by the fotal time can be applied equally to calculate a safe total dose or time in another patient. There is very little evidence to support this. It may well be that 5 mg./day can be tolerated for much longer than twice the time which the same patient can tolerate 10 mg./day, and very probably for much longer than four times the same patient's endurance at 20 mg./day.
Therefore the kind of study reported here, in which the patients are all taking the same daily dose for various times, is more likely to produce a clear picture of at least a segment of what may be a three 5 mg. prednisone is the equivalent of the daily adrenal glucocorticoid output (Peterson and Wyngaarden, 1956 ). Shuster and Williams (1961) found dimensional graph. The study shows that the daily dose of 5 mg./day prednisone is not free of the danger of adrenal suppression; moreover, even from a study concentrated on only one aspect of the time/dose relationship, it is not possible to predict the onset of adrenal suppression. Individual testing is therefore necessary. The results from those patients whose adrenal function was tested on a second occasion suggest that, while the onset of adrenal suppression is so greatly influenced by the individual sensitivity as to appear random, the progress of each patients adrenal function seems to follow simple pharmacological concepts, tending to deteriorate where prednisone is continued at the same daily level or increased, and tending to improve where the daily dose is adequately reduced or discontinued. Summary 39 patients on prolonged low doses of steroids were studied by the Synacthen test for evidence of adrenal suppression. Four had unequivocally abnormal tests. No abnormality occurred before the end of one year, but thereafter there was no relationship between total dose, total time, and onset of suppression.
Nineteen of the patients were re-tested after an interval of one year to assess the effects of altered or continued steroid therapy.
The dose level of 5 mg./day prednisone is not free of the danger of adrenal suppression. The variation in individual sensitivity is so great that predictions cannot be made, and each patient must be treated separately. Adrenal function proceeds as might be expected from a simple dose-response relationship when studied over a period of time, but individual variability is still evident. 
